Boone Capital Management LLC
In its 13F for Q1 2026 (holdings as of March 31, 2026, filed May 15, 2026), Boone Capital Management LLC reported 13 stock positions worth $326.4 million. Its top holding was Mirum Pharmaceuticals (MIRM) at 11.9% of the portfolio, followed by Ionis Pharmaceuticals (IONS, 11.5%) and Cigna (CI, 11.2%). Compared with Q4 2025, it opened 4 new positions, sold out of 6, added to 5 and reduced 2. The biggest buy was a new position in Teleflex (TFX) and the biggest sale an exit from Neurocrine Biosciences (NBIX).
- Most Recent 13F
- Q2 2026
- Location
- ATLANTA, GA
- CIK
- 0001882053
- Portfolio Value
- $326.4M (Q1 2026)
- SEC Filing
- 0001214659-26-006448 ↗ filed May 15, 2026
Holdings Value
Holdings 13 stocks · $326.4M
| MIRM Mirum Pharmaceuticals Inc. | 11.92% | 421,236 | $38.9M | No change |
| IONS Ionis Pharmaceuticals Inc. | 11.51% | 500,522 | $37.6M | Add +19.8% |
| CI The Cigna Group | 11.24% | 137,522 | $36.7M | Add +42.6% |
| MDT Medtronic PLC | 10.57% | 398,065 | $34.5M | Reduce -7.2% |
| TFX Teleflex Inc. | 10.22% | 278,792 | $33.3M | New |
| BMRN Biomarin Pharmaceutical Inc. | 9.48% | 547,871 | $30.9M | Add +33.0% |
| GRDN Guardian Phrmcy Services-A | 7.28% | 631,193 | $23.8M | New |
| AZN Astrazeneca PLC | 6.65% | 110,101 | $21.7M | No change |
| UNH Unitedhealth Group Inc. | 6.57% | 79,226 | $21.4M | Add +28.3% |
| BBIO Bridgebio Pharma Inc. | 5.21% | 228,829 | $17.0M | Add +23.7% |
| AVNS Avanos Medical Inc. | 5.09% | 1,184,909 | $16.6M | New |
| KOD Kodiak Sciences Inc. | 3.29% | 281,332 | $10.7M | Reduce -44.2% |
| TENX Tenax Therapeutics Inc. | 0.98% | 200,000 | $3.2M | New |
Portfolio Sells Q4 2025 → Q1 2026
| NBIX Neurocrine Biosciences Inc. | Sold out | 0.00% | −6.76 |
| HQY Healthequity Inc. | Sold out | 0.00% | −6.12 |
| LIVN Livanova PLC | Sold out | 0.00% | −5.58 |
| RAPT Rapt Therapeutics Inc. | Sold out | 0.00% | −5.00 |
| TYRA Tyra Biosciences Inc. | Sold out | 0.00% | −3.29 |
| MDT Medtronic PLC | Reduce -7.2% | 10.57% | −2.36 |
| WVE Wave Life Sciences Ltd. | Sold out | 0.00% | −1.88 |
| KOD Kodiak Sciences Inc. | Reduce -44.2% | 3.29% | −1.14 |
Portfolio Buys Q4 2025 → Q1 2026
| TFX Teleflex Inc. | New | 10.22% | +10.22 |
| GRDN Guardian Phrmcy Services-A | New | 7.28% | +7.28 |
| AVNS Avanos Medical Inc. | New | 5.09% | +5.09 |
| CI The Cigna Group | Add +42.6% | 11.24% | +2.91 |
| BMRN Biomarin Pharmaceutical Inc. | Add +33.0% | 9.48% | +1.80 |
| IONS Ionis Pharmaceuticals Inc. | Add +19.8% | 11.51% | +1.14 |
| TENX Tenax Therapeutics Inc. | New | 0.98% | +0.98 |
| BBIO Bridgebio Pharma Inc. | Add +23.7% | 5.21% | +0.77 |
| UNH Unitedhealth Group Inc. | Add +28.3% | 6.57% | +0.17 |
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 16 | $427.5M | TFX, MIRM, CI, IONS, UNH |
| Q1 2026 | 13 | $326.4M | MIRM, IONS, CI, MDT, TFX |
| Q4 2025 | 15 | $318.6M | MDT, MIRM, IONS, CI, BMRN |
| Q3 2025 | 16 | $305.0M | MDT, MIRM, IONS, CI, BBIO |
| Q2 2025 | 11 | $233.2M | MDT, MIRM, BMRN, AVTR, UNM |
| Q1 2025 | 12 | $293.8M | UNM, MDT, MIRM, GMED, CI |
| Q4 2024 | 13 | $296.5M | UNM, GMED, PRGO, MIRM, MOH |
| Q3 2024 | 17 | $385.8M | UNM, GMED, CI, MOH, CHE |
| Q2 2024 | 19 | $383.4M | UNM, GMED, CI, MOH, DHR |
| Q1 2024 | 21 | $494.4M | UNM, CI, MOH, ENOV, BAX |